MSOS ETF Flipped to Buy Due to Regulatory Momentum

about 1 month ago

Emma Johnston

"So that is definitely one of the areas that's allowing MSOS to get into the buy category. It was a sell as recently as August 11th, but the news around potential descheduling of cannabis in the U.S. has propelled its momentum."

MSOS, the Advisor Shares Pure U.S. Cannabis ETF with approximately $840M in assets, has shifted its quant rating from sell to buy. Increased attention on regulatory changes, particularly potential descheduling, has boosted its momentum and liquidity, making it an actionable opportunity for investors seeking exposure to the U.S. cannabis market.

Related Stocks